Debby Thomas

11PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)PharmacogenomicsStochastic analysis and modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 01, 2023
Evaluation of serum cytokines and acute phase proteins as possible pharmacodynamic biomarkers to monitor endoscopic remission during ustekinumab therapy in patients with Crohn's disease.

Nathalie Van den Berghe, Dahham Alsoud, Bram Verstockt

|Feb 25, 2023
Detection of Breast Cancer-Specific Extracellular Vesicles with Fiber-Optic SPR Biosensor.

Yagmur Yildizhan, Kaat Driessens, Hong Shen Kevin Tsao

|Jan 20, 2023
A Model-Based Tool for Guiding Infliximab Induction Dosing to Maximize Long-term Deep Remission in Children with Inflammatory Bowel Diseases.

Wannee Kantasiripitak, Sebastian G Wicha, Debby Thomas

|Jun 16, 2022
Multi-model averaging improves the performance of model-guided infliximab dosing in patients with inflammatory bowel diseases.

Wannee Kantasiripitak, An Outtier, Sebastian G Wicha

|May 09, 2022
Real-world Endoscopic and Histological Outcomes Are Correlated with Ustekinumab Exposure in Patients with Ulcerative Colitis.

Dahham Alsoud, Gert De Hertogh, Griet Compernolle

|Mar 04, 2022
Therapeutic drug monitoring in dermatology: the way towards dose optimization of secukinumab in chronic plaque psoriasis.

Rani Soenen, Zhigang Wang, Lynda Grine

Pageof 2

Frequent Collaborators

4 joint publications

Erwin Dreesen

3 joint publications

Marc Ferrante

3 joint publications

Bram Verstockt

3 joint publications

Séverine Vermeire